GPT and metabolic dysfunction-associated steatotic liver disease: Sixty-three overweight or obese patients with ultrasonography-proven NAFLD and elevated alanine aminotransferase and/or gamma-glutamlyl-transpeptidase were randomized to a control group, or to MD or Mediterranean lifestyle (ML) groups.